acquired
Stage
1
Investors
About
IFM Therapeutics develops first-in-class small molecule therapeutics targeting the innate immune system to treat inflammation-driven diseases and cancer.
Explore IFM Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.